The dilution related to the share registration has been known for many months, ever since the LPC funding was announced. It's not new news. There will be dilution as the company draws on additional funds per the agreement, but it doesn't happen all at once. It's entirely possible the full $20M in funding won't be needed if/when sources such as grants, partnership payments, and LymPro revenues are available to fund the company's operations. The dilution from this funding may be less than expected if any of these sources replace the funds needed.
I suppose it might cause concern to shareholders who don't understand the difference between the previous registration statement and the effectiveness statement, believing there is more dilution than what is actually planned. We saw this confusion in the past. Hopefully now most longs understand it, and it shouldn't matter much to the flippers. Still, some may try to instill dilution fears into shareholders who are unfamiliar with the purpose of these filings.
To Orion1983: Us? You are no longer a shareholder, as per your recent posts, correct? The TBI connection is an ongoing thing. The company is involved with partners who are bringing more attention to the issue. Governments, corporations and even colleges/high schools are getting involved. What exactly is your concern? The company is aligning themselves and developing strategic partnerships to be a part of the solution. This doesn't happen overnight. Neither does success for the company and as a shareholder in the investment. I've been a shareholder for less than 2 years, and I am very happy with the company progress during that time, and my investment gains. I fully expect those gains to be orders of magnitude greater over the coming years, and likely the best investment I've ever made. Obviously I don't share your concerns over the company's efforts in TBI. Nice to see all of these concerns posted while being out of the stock. Suspicious, to say the least.
